Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04675723Completed
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
Clostridioides Difficile Infection
PrincipalinvestigatorStart date: 2019-09-23
NCT04679324Withdrawn
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
Clostridioides Difficile Infection
PrincipalinvestigatorStart date: 2019-09-23
NCT04668014Completed
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
Clostridioides Difficile Infection
PrincipalinvestigatorStart date: 2019-09-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Patrice Allibert

Meridian Bioscience, Inc.

Moderately Similar
3 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Judit Szabo, M.D., Ph.D.

University of Debrecen

Moderately Similar
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Eva Rakoczi, M.D.

Kenezy Gyula Korhaz es Rendelointezet

Moderately Similar
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Sabine Hazan, MD

ProgenaBiome

Moderately Similar
41 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Evangelos J Giamarellos-Bourboulis, MD, Phd

Hellenic Sepsis Study Group

Moderately Similar
3 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Donna Holton, MD

Calgary Health Region

Moderately Similar
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Istvan Varkonyi, M.D.

Kenezy Gyula Korhaz es Rendelointezet

Moderately Similar
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Tibor Pap, M.D.

Miskolci Semmelweis Korhaz es Egyetemi Oktatokorhaz

Moderately Similar
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Darrell Pardi, MD

Mayo Clinic

Moderately Similar
3 trials

Shared therapeutic areas:

Clostridium difficile Infections

Worked with same sponsors:

Mayo Clinic
Similarity Score30%

Gergely G Nagy, M.D., Ph.D.

University of Debrecen

Moderately Similar
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04675723PrincipalInvestigator

The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection

Clostridioides Difficile Infection
Completed
NCT04679324PrincipalInvestigator

The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection

Clostridioides Difficile Infection
Withdrawn
NCT04668014PrincipalInvestigator

The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection

Clostridioides Difficile Infection
Completed

All 3 trials loaded